Cargando…
Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943290/ https://www.ncbi.nlm.nih.gov/pubmed/27021567 http://dx.doi.org/10.1161/JAHA.116.003440 |
| _version_ | 1782442568534982656 |
|---|---|
| author | Luzum, Jasmine A. Lanfear, David E. |
| author_facet | Luzum, Jasmine A. Lanfear, David E. |
| author_sort | Luzum, Jasmine A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4943290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49432902016-07-20 Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? Luzum, Jasmine A. Lanfear, David E. J Am Heart Assoc Editorial John Wiley and Sons Inc. 2016-03-28 /pmc/articles/PMC4943290/ /pubmed/27021567 http://dx.doi.org/10.1161/JAHA.116.003440 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Editorial Luzum, Jasmine A. Lanfear, David E. Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title | Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title_full | Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title_fullStr | Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title_full_unstemmed | Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title_short | Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? |
| title_sort | pharmacogenetic risk scores for perindopril clinical and cost effectiveness in stable coronary artery disease: when are we ready to implement? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943290/ https://www.ncbi.nlm.nih.gov/pubmed/27021567 http://dx.doi.org/10.1161/JAHA.116.003440 |
| work_keys_str_mv | AT luzumjasminea pharmacogeneticriskscoresforperindoprilclinicalandcosteffectivenessinstablecoronaryarterydiseasewhenarewereadytoimplement AT lanfeardavide pharmacogeneticriskscoresforperindoprilclinicalandcosteffectivenessinstablecoronaryarterydiseasewhenarewereadytoimplement |